4
Changes in Ownership
Axogen, Inc. Filed Acc 0001179110-20-012175
VP, Clinical&Translational Sc sold 147 shares at $16.42 ($2,414)
- VP, Clinical&Translational Sc acquired 575 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-18 | Grant or award | +575 | 62,258 | D | ||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-21 | Sale | −147 | $16.42 | $2,414 | 62,111 | D |
| Open-market sales · 147 sh · avg $16.42 · $2,414 | |||||||
Loading xslF345X03/edgar.xml…